Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan

References

• LimSSVosTFlaxmanADA comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet20123802224226023245609
   PubMed Web of Science ®Google Scholar
• LawesCMVander HoornSRodgersAInternational Society of HypertensionGlobal burden of blood-pressure-related disease, 2001Lancet200837196231513151818456100
   PubMed Web of Science ®Google Scholar
• KearneyPMWheltonMReynoldsKMuntnerPWheltonPKHeJGlobal burden of hypertension: analysis of worldwide dataLancet2005365945521722315652604
   PubMed Web of Science ®Google Scholar
• FangJMadhavanSCohenHAldermanMHMeasures of blood pressure and myocardial infarction in treated hypertensive patientsJ Hypertens19951344134197629401
   PubMed Web of Science ®Google Scholar
• LiuLZhangYLiuGLiWZhangXZanchettiAFever Study GroupThe Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patientsJ Hypertens200523122157217216269957
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRThe seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 reportJAMA2003289192560257212748199
   PubMed Web of Science ®Google Scholar
• DienerHCBogousslavskyJBrassLMAspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialLancet2004364943133133715276392
   PubMed Web of Science ®Google Scholar
• GlynnRJL’ItalienGJSessoHDJacksonEABuringJEDevelopment of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressureHypertension200239110511011799087
   PubMed Web of Science ®Google Scholar
• BarrerasAGurk-TurnerCAngiotensin II receptor blockersProc (Bayl Univ Med Cent)200316112312616278727
   PubMedGoogle Scholar
• WongMCJiangJYLamATFungHGriffithsSMercerSWPatterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptionsJ Hum Hypertens2008221071471618650836
   PubMed Web of Science ®Google Scholar
• ZhangJFMedication use among hypertension patients in a Chinese hospitalChina Pract Med2009522111112
   Google Scholar
• Medical and Pharmaceutical Industry Technology and Development Center, Taiwan, ROCOverview of the Anti-Hypertensive Drugs Market [in Chinese] Available from: http://www.pitdc.org.tw/member/%E4%B8%AD%E8%A5%BF%E8%97%A5%E5%B8%82%E5%A0%B4/%E8%A5%BF%E8%97%A5/%E9%AB%98%E8%A1%80%E5%A3%93%E6%B2%BB%E7%99%82%E8%97%A5%E5%B8%82%E5%A0%B4%E6%A6%82%E8%BF%B0-%E4%B8%8A.pdfAccessed January 25, 2016
   Google Scholar
• ChenWXTanXA review of the utilization of oral calcium channel blockersCurr Pharm Today (Chinese)20091953133
   Google Scholar
• Pfizer IncNorvasc tablets [US package insert] Available from: http://labeling.pfizer.com/ShowLabeling.aspx?id=562Accessed December 10, 2014
   Google Scholar
• de PortuSMantovaniLGAmlodipine: a pharmacoeconomic reviewJ Med Econ2009121606819450066
   PubMedGoogle Scholar
• WuYZhouQXuanJA cost-effectiveness analysis between Norvasc angiotensin II receptor blockers in stroke and myocardial infarction prevention among hypertension patients in ChinaValue Health Reg Issues201327580
   Google Scholar
• SinghRBSuhILSinghVPHypertension and stroke in Asia: prevalence, control and strategies in developing countries for preventionJ Hum Hypertens20001410–1174976311095165
   PubMed Web of Science ®Google Scholar
• Department of Health, Executive Yuan, R.O.C. (Taiwan)2010 Statistics for Causes of Death Available from: http://www.mohw.gov.tw/MOHW_Upload/doc/2010-statistics%20of%20cause%20of%20death.pdfAccessed January 29, 2014
   Google Scholar
• Department of Health EY, R.O.C., (Taiwan)2010 Statistical Annual Report of Medical Care, National Health Insurance Available from: http://www.mohw.gov.tw/EN/Ministry/Statistic_P.aspx?f_list_no=474&fod_list_no=3477&doc_no=27787Accessed November 13, 2015
   Google Scholar
• MuramatsuTMatsushitaKYamashitaKNAGOYA HEART Study InvestigatorsComparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART StudyHypertension201259358058622232134
   PubMed Web of Science ®Google Scholar
• LeeYLinRSSungFCChin-Shan community cardiovascular cohort in Taiwan-baseline data and five-year follow-up morbidity and mortalityJ Clin Epidemiol200053883884610942867
   PubMed Web of Science ®Google Scholar
• WangJGLiYFranklinSSSafarMPrevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overviewHypertension200750118118817502490
   PubMed Web of Science ®Google Scholar
• ChangKCLeeHCTsengMCHuangYCThree-year survival after first-ever ischemic stroke is predicted by initial stroke severity: a hospital-based studyClin Neurol Neurosurg2010112429630120106589
   PubMed Web of Science ®Google Scholar
• LeeCHChengCLYangYHTrends in the incidence and management of acute myocardial infarction from 1999 to 2008: get with the guidelines performance measures in TaiwanJ Am Heart Assoc201434e00106625112555
   PubMed Web of Science ®Google Scholar
• ChiangFTShyuKGWuCJPredictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum RegistryJ Formos Med Assoc20141131179480224076272
   PubMed Web of Science ®Google Scholar
• National Health Insurance Administration MoHaWNational Health Insurance reimbursed drug price [in Chinese] Available from: http://www.nhi.gov.tw/query/query1.aspx?menu=21&menu_id=713&webdata_id=3510&WD_ID=851Accessed December 31, 2014
   Google Scholar
• TangCHChuangPYChenCAFangYCMedical costs of cardiovascular diseases in TaiwanValue Health Reg Issues2014177A759A760
   Google Scholar
• SunSChenJJohannessonMPopulation health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008Qual Life Res201120330932021042861
   PubMed Web of Science ®Google Scholar
• ReidCMYanBWan AhmadWAThe Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) collaboration – improving the quality of cardiovascular care in the Asia Pacific regionInt J Cardiol20141721727524480180
   PubMed Web of Science ®Google Scholar
• AraRTumurIPandorAEzetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluationHealth Technol Assess20081221iiixixiii121218485273
   PubMed Web of Science ®Google Scholar
• HataJKiyoharaYEpidemiology of stroke and coronary artery disease in AsiaCirc J20137781923193223842096
   PubMed Web of Science ®Google Scholar
• ChiangCEWangTDUengKC2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertensionJ Chin Med Assoc201578114725547819
   PubMed Web of Science ®Google Scholar
• ChenXZhouLZhangYRisk factors of stroke in Western and Asian countries: a systematic review and meta-analysis of prospective cohort studiesBMC Public Health20141477625081994
   PubMed Web of Science ®Google Scholar
• ThorvaldsenPKuulasmaaKRajakangasAMRastenyteDSartiCWilhelmsenLStroke trends in the WHO MONICA projectStroke19972835005069056602
   PubMed Web of Science ®Google Scholar
• SullivanSDAveySGFlynnJAThe AMCP format for formulary submissions (version 3.0): a format for submission of clinical and economic evidence of pharmaceuticals in support of formulary consideration Available from: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=9127Accessed November 13, 2015
   Google Scholar
• LeeHYHwangJSJengJSWangJDQuality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-upStroke201041473974420150543
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Welfare2009 statistics of causes of death Available from: http://www.mohw.gov.tw/EN/Ministry/Statistic.aspx?f_list_no=474&fod_list_no=3481Accessed August 1, 2015
   Google Scholar